Esrum Biotech ApS: Financial statements 2025
CVR: 43131761
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Esrum Biotech ApS (CVR 43131761) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 246,808 and a net result of DKK 95,817 compared with DKK 1,202,026 the year before. That is a decrease of 86% compared with the year before. Equity in the 2025 report amounted to DKK 135,817. The solvency ratio was 17%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 246,808
- Profit/Loss
- DKK 95,817
- Equity
- DKK 135,817
- Total Assets
- DKK 798,057
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 247 t. | 96 t. | 136 t. | 1 |
| 2024 | - | 1.8 mio. | 1.2 mio. | 3.6 mio. | 1 |
| 2023 | - | 2 mio. | 1.5 mio. | 2.4 mio. | 1 |
Official annual report
How creditworthy is Esrum Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Esrum Biotech ApS has published its annual report for 2024. Gross profit came to DKK 1,762,824, and the net result was DKK 1,202,026.
About Esrum Biotech ApS
Esrum Biotech ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mette Kirstine Agger. The company is owned by Esrum Biotech Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 246,808 and a net result of DKK 95,817 compared with DKK 1,202,026 the year before. Equity in the 2025 report amounted to DKK 135,817.